Pharmacyclics, Inc.’s (PCYC) MACD indicator has entered into bearish territory with a reading of -0.0076. The Zacks #5 Rank (“Strong Sell”) stock decreased 1.1% to $7.27 in morning trade. The Zacks Consensus Estimate for the year ending June 2011 has worsened by 23 cents over the past two months to a loss of 53 cents per share.
 
PHARMACYCLICS (PCYC): Free Stock Analysis Report
 
Zacks Investment Research